COVID-19 2021 - Future of Real-World Evidence: Common Data Models and OHDSI Tools Used in the COVID-Real Case Study
Topics/Call fo Papers
Who Should Attend?
This webinar will be of interest to those working in the following areas:
Observational Research
Real World Evidence
Epidemiology
Medical Affairs
Digital Health/Solutions/Innovation
Clinical Development
Clinical Operations
Pharmaceutical/Biotechnology/Medical Device Companies
Statistics/Biometrics/Data Managers
Data Analysts/Data Engineers
Clinicians/Physicians/Nurses
IT/Hospital Information Systems
R&D
Scientific Studies
HEOR/HTA/Market Access
What You Will Learn
In this webinar, participants will learn answers to key questions, including:
What is the future of RWE? How can health data be analyzed in near-real-time using high-quality methods?
What is a Common Data Model and what is OMOP?
How is OMOP analyzed using global OHDSI tools?
What are the main regulatory, methodological and technical challenges of OMOP-based RWE research?
This webinar will be of interest to those working in the following areas:
Observational Research
Real World Evidence
Epidemiology
Medical Affairs
Digital Health/Solutions/Innovation
Clinical Development
Clinical Operations
Pharmaceutical/Biotechnology/Medical Device Companies
Statistics/Biometrics/Data Managers
Data Analysts/Data Engineers
Clinicians/Physicians/Nurses
IT/Hospital Information Systems
R&D
Scientific Studies
HEOR/HTA/Market Access
What You Will Learn
In this webinar, participants will learn answers to key questions, including:
What is the future of RWE? How can health data be analyzed in near-real-time using high-quality methods?
What is a Common Data Model and what is OMOP?
How is OMOP analyzed using global OHDSI tools?
What are the main regulatory, methodological and technical challenges of OMOP-based RWE research?
Other CFPs
- What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?
- What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?
- Utilising a Virtual Central Laboratory Approach to Balance the Delivery, Budget and Risk for Clinical Trials
- Whole-Body MRI Composite Scoring in Neuromuscular Disease Research & Muscle Health
- How to Optimize Customs Taxes for Clinical Trials in Eastern Europe
Last modified: 2021-11-18 04:22:24